Search Keyword:


Search option:


IID00708
UniprotP12931
ProteinProto-oncogene tyrosine-protein kinase Src
GeneSRC
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
536
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 2-536 Monomer :
 Evidence X-RAY 1y57 A Reference
       Region 1y57 A 86-536 order
 Evidence X-RAY 2src A Reference
       Region 2src A 86-86 disorder
       Region 2src A 87-536 order
 Evidence X-RAY 1ksw A Reference
       Region 1ksw A 86-86 disorder
       Region 1ksw A 87-536 order
 Evidence X-RAY 4k11 A Reference
       Region 4k11 A 87-534 order
 Evidence X-RAY 2h8h A Reference
       Region 2h8h A 2-87 disorder
       Region 2h8h A 88-532 order
       Region 2h8h A 533-536 disorder
 Evidence X-RAY 1fmk A Reference
       Region 1fmk A 86-412 order
       Region 1fmk A 413-426 disorder
       Region 1fmk A 427-536 order
Seq 87-144 Hetero trimer :
 Evidence X-RAY 4hxj B Reference
       Region 4hxj B 87-144 order
 Evidence X-RAY 4hxj A Reference
       Region 4hxj A 87-144 order
Seq 144-249 Homo dimer :
 Evidence X-RAY 1a1e B Reference
       Region 1a1e B 144-145 disorder
       Region 1a1e B 146-249 order
 Evidence X-RAY 1a1e A Reference
       Region 1a1e A 144-145 disorder
       Region 1a1e A 146-249 order
 Evidence X-RAY 1a1c B Reference
       Region 1a1c B 144-145 disorder
       Region 1a1c B 146-249 order
 Evidence X-RAY 1a1c A Reference
       Region 1a1c A 144-144 disorder
       Region 1a1c A 145-249 order
 Evidence X-RAY 1a1b B Reference
       Region 1a1b B 144-145 disorder
       Region 1a1b B 146-249 order
 Evidence X-RAY 1a1b A Reference
       Region 1a1b A 144-144 disorder
       Region 1a1b A 145-249 order
 Evidence X-RAY 1a1a B Reference
       Region 1a1a B 144-147 disorder
       Region 1a1a B 148-249 order
 Evidence X-RAY 1a1a A Reference
       Region 1a1a A 144-249 order
 Evidence X-RAY 1a09 B Reference
       Region 1a09 B 144-147 disorder
       Region 1a09 B 148-249 order
 Evidence X-RAY 1a09 A Reference
       Region 1a09 A 144-249 order
 Evidence X-RAY 1a07 B Reference
       Region 1a07 B 144-145 disorder
       Region 1a07 B 146-249 order
 Evidence X-RAY 1a07 A Reference
       Region 1a07 A 144-144 disorder
       Region 1a07 A 145-249 order
Seq 144-252 Monomer :
 Evidence NMR 1hct B Reference
       Region 1hct B 144-249 order
       Region 1hct B 144-144 high_rmsd
 Evidence NMR 1hcs B Reference
       Region 1hcs B 144-249 order
 Evidence X-RAY 1shd A Reference
       Region 1shd A 144-144 disorder
       Region 1shd A 145-181 order
       Region 1shd A 182-185 disorder
       Region 1shd A 186-249 order
 Evidence X-RAY 1o4r A Reference
       Region 1o4r A 145-249 order
       Region 1o4r A 250-252 disorder
 Evidence X-RAY 1o4q A Reference
       Region 1o4q A 145-250 order
       Region 1o4q A 251-252 disorder
 Evidence X-RAY 1o4p A Reference
       Region 1o4p A 145-249 order
       Region 1o4p A 250-252 disorder
 Evidence X-RAY 1o4o A Reference
       Region 1o4o A 145-250 order
       Region 1o4o A 251-252 disorder
 Evidence X-RAY 1o4n A Reference
       Region 1o4n A 145-250 order
       Region 1o4n A 251-252 disorder
 Evidence X-RAY 1o4m A Reference
       Region 1o4m A 145-249 order
       Region 1o4m A 250-252 disorder
 Evidence X-RAY 1o4l A Reference
       Region 1o4l A 145-249 order
       Region 1o4l A 250-252 disorder
 Evidence X-RAY 1o4k A Reference
       Region 1o4k A 145-250 order
       Region 1o4k A 251-252 disorder
 Evidence X-RAY 1o4j A Reference
       Region 1o4j A 145-250 order
       Region 1o4j A 251-252 disorder
 Evidence X-RAY 1o4i A Reference
       Region 1o4i A 145-250 order
       Region 1o4i A 251-252 disorder
 Evidence X-RAY 1o4h A Reference
       Region 1o4h A 145-250 order
       Region 1o4h A 251-252 disorder
 Evidence X-RAY 1o4g A Reference
       Region 1o4g A 145-250 order
       Region 1o4g A 251-252 disorder
 Evidence X-RAY 1o4f A Reference
       Region 1o4f A 145-249 order
       Region 1o4f A 250-252 disorder
 Evidence X-RAY 1o4e A Reference
       Region 1o4e A 145-250 order
       Region 1o4e A 251-252 disorder
 Evidence X-RAY 1o4d A Reference
       Region 1o4d A 145-249 order
       Region 1o4d A 250-252 disorder
 Evidence X-RAY 1o4c A Reference
       Region 1o4c A 145-249 order
       Region 1o4c A 250-252 disorder
 Evidence X-RAY 1o4b A Reference
       Region 1o4b A 145-250 order
       Region 1o4b A 251-252 disorder
 Evidence X-RAY 1o4a A Reference
       Region 1o4a A 145-250 order
       Region 1o4a A 251-252 disorder
 Evidence X-RAY 1o49 A Reference
       Region 1o49 A 145-250 order
       Region 1o49 A 251-252 disorder
 Evidence X-RAY 1o48 A Reference
       Region 1o48 A 145-250 order
       Region 1o48 A 251-252 disorder
 Evidence X-RAY 1o47 A Reference
       Region 1o47 A 145-250 order
       Region 1o47 A 251-252 disorder
 Evidence X-RAY 1o46 A Reference
       Region 1o46 A 145-250 order
       Region 1o46 A 251-252 disorder
 Evidence X-RAY 1o45 A Reference
       Region 1o45 A 145-250 order
       Region 1o45 A 251-252 disorder
 Evidence X-RAY 1o44 A Reference
       Region 1o44 A 145-250 order
       Region 1o44 A 251-252 disorder
 Evidence X-RAY 1o43 A Reference
       Region 1o43 A 145-250 order
       Region 1o43 A 251-252 disorder
 Evidence X-RAY 1o42 A Reference
       Region 1o42 A 145-250 order
       Region 1o42 A 251-252 disorder
 Evidence X-RAY 1o41 A Reference
       Region 1o41 A 145-250 order
       Region 1o41 A 251-252 disorder
 Evidence X-RAY 4f5b A Reference
       Region 4f5b A 144-251 order
       Region 4f5b A 252-252 disorder
 Evidence X-RAY 4f5a A Reference
       Region 4f5a A 144-251 order
       Region 4f5a A 252-252 disorder
 Evidence X-RAY 4f59 A Reference
       Region 4f59 A 144-251 order
       Region 4f59 A 252-252 disorder
 Evidence X-RAY 1a08 B Reference
       Region 1a08 B 144-145 disorder
       Region 1a08 B 146-249 order
 Evidence X-RAY 1a08 A Reference
       Region 1a08 A 144-144 disorder
       Region 1a08 A 145-249 order
Seq 254-536 Monomer :
 Evidence X-RAY 1yom B Reference
       Region 1yom B 254-257 disorder
       Region 1yom B 258-408 order
       Region 1yom B 409-426 disorder
       Region 1yom B 427-536 order
 Evidence X-RAY 1yom A Reference
       Region 1yom A 254-257 disorder
       Region 1yom A 258-407 order
       Region 1yom A 408-426 disorder
       Region 1yom A 427-536 order
 Evidence X-RAY 1yol B Reference
       Region 1yol B 254-261 disorder
       Region 1yol B 262-279 order
       Region 1yol B 280-281 disorder
       Region 1yol B 282-407 order
       Region 1yol B 408-427 disorder
       Region 1yol B 428-536 order
 Evidence X-RAY 1yol A Reference
       Region 1yol A 254-258 disorder
       Region 1yol A 259-279 order
       Region 1yol A 280-281 disorder
       Region 1yol A 282-407 order
       Region 1yol A 408-427 disorder
       Region 1yol A 428-536 order
 Evidence X-RAY 1yoj B Reference
       Region 1yoj B 254-271 disorder
       Region 1yoj B 272-276 order
       Region 1yoj B 277-282 disorder
       Region 1yoj B 283-284 order
       Region 1yoj B 285-292 disorder
       Region 1yoj B 293-300 order
       Region 1yoj B 301-317 disorder
       Region 1yoj B 318-408 order
       Region 1yoj B 409-427 disorder
       Region 1yoj B 428-536 order
 Evidence X-RAY 1yoj A Reference
       Region 1yoj A 254-263 disorder
       Region 1yoj A 264-278 order
       Region 1yoj A 279-281 disorder
       Region 1yoj A 282-300 order
       Region 1yoj A 301-316 disorder
       Region 1yoj A 317-406 order
       Region 1yoj A 407-427 disorder
       Region 1yoj A 428-536 order
 Evidence X-RAY 1yi6 B Reference
       Region 1yi6 B 261-536 order
 Evidence X-RAY 1yi6 A Reference
       Region 1yi6 A 261-536 order
 Evidence X-RAY 4mxz B Reference
       Region 4mxz B 254-260 disorder
       Region 4mxz B 261-414 order
       Region 4mxz B 415-426 disorder
       Region 4mxz B 427-536 order
 Evidence X-RAY 4mxz A Reference
       Region 4mxz A 254-259 disorder
       Region 4mxz A 260-415 order
       Region 4mxz A 416-426 disorder
       Region 4mxz A 427-536 order
 Evidence X-RAY 4mxy B Reference
       Region 4mxy B 254-260 disorder
       Region 4mxy B 261-414 order
       Region 4mxy B 415-426 disorder
       Region 4mxy B 427-536 order
 Evidence X-RAY 4mxy A Reference
       Region 4mxy A 254-259 disorder
       Region 4mxy A 260-415 order
       Region 4mxy A 416-426 disorder
       Region 4mxy A 427-536 order
 Evidence X-RAY 4mxx B Reference
       Region 4mxx B 254-260 disorder
       Region 4mxx B 261-410 order
       Region 4mxx B 411-426 disorder
       Region 4mxx B 427-536 order
 Evidence X-RAY 4mxx A Reference
       Region 4mxx A 254-259 disorder
       Region 4mxx A 260-415 order
       Region 4mxx A 416-426 disorder
       Region 4mxx A 427-536 order
 Evidence X-RAY 4mxo B Reference
       Region 4mxo B 254-260 disorder
       Region 4mxo B 261-414 order
       Region 4mxo B 415-426 disorder
       Region 4mxo B 427-536 order
 Evidence X-RAY 4mxo A Reference
       Region 4mxo A 254-259 disorder
       Region 4mxo A 260-415 order
       Region 4mxo A 416-426 disorder
       Region 4mxo A 427-536 order
 Evidence X-RAY 2bdj A Reference
       Region 2bdj A 258-259 disorder
       Region 2bdj A 260-415 order
       Region 2bdj A 416-426 disorder
       Region 2bdj A 427-524 order
       Region 2bdj A 525-536 disorder
 Evidence X-RAY 2bdf B Reference
       Region 2bdf B 258-415 order
       Region 2bdf B 416-424 disorder
       Region 2bdf B 425-531 order
       Region 2bdf B 532-536 disorder
 Evidence X-RAY 2bdf A Reference
       Region 2bdf A 258-259 disorder
       Region 2bdf A 260-415 order
       Region 2bdf A 416-426 disorder
       Region 2bdf A 427-531 order
       Region 2bdf A 532-536 disorder
Seq 412-424 Hetero dimer : IID00287Complex
 Evidence X-RAY 3vro B Reference
       Region 3vro B 412-416 disorder
       Region 3vro B 417-421 order
       Region 3vro B 422-424 disorder
Seq 527-536 Hetero dimer : P18031
 Evidence X-RAY 3zmq C Reference
       Region 3zmq C 527-532 order
       Region 3zmq C 533-536 disorder
 Evidence X-RAY 3zmp C Reference
       Region 3zmp C 527-535 order
       Region 3zmp C 536-536 disorder
 Evidence X-RAY 3zmp D Reference
       Region 3zmp D 527-528 disorder
       Region 3zmp D 529-531 order
       Region 3zmp D 532-536 disorder
Seqphosphorylation
    75-75 Phosphoserine; by CDK5
    17-17 Phosphoserine
    187-187 Phosphotyrosine
    419-419 Phosphotyrosine; by autocatalysis
    530-530 Phosphotyrosine; by CSK
    419-419 Phosphotyrosine; by FAK2
 
Prediction
NeProc
Disorder 1-84,527-536
Order 85-526
ProS 1-9,18-23,30-34,44-53,527-536
AlphaFold
Disorder 1-86,416-425,524-528,533-536
Order 87-415,426-523,529-532
Pfam Hmmer
PF00018 87-143 1.4e-26
PF00017 151-233 2.5e-43
PF07714 270-519 4e-151
SEG 52-59
Function
Function in SwissProt
Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (PubMed:21411625). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors (By similarity). Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1 (PubMed:11389730). Plays a role in EGF-mediated calcium-activated chloride channel activation (PubMed:18586953). Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable). Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus (PubMed:7853507). Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function (PubMed:8755529, PubMed:14585963). Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase (PubMed:12615910). Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation (PubMed:16186108). Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731' (PubMed:20100835, PubMed:21309750). Enhances DDX58/RIG-I-elicited antiviral signaling (PubMed:19419966). Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (PubMed:14585963). Phosphorylates BCAR1 at 'Tyr-128' (PubMed:22710723). Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity (PubMed:20525694). Involved in anchorage-independent cell growth (PubMed:19307596). Required for podosome formation (By similarity). Mediates IL6 signaling by activating YAP1-NOTCH pathway to induce inflammation-induced epithelial regeneration (PubMed:25731159).
Biological Process
Diagram with PDB data
SRCCRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP
See also
Diagram with PDB data
ANXA2Crystal structure of Tyr24 phosphorylated Annexin A2 at 2.9 A resolution
ERRFI1/EGFRcrystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein